Philip Morris to acquire Fertin Pharma for $812.8m
Philip Morris International has signed an agreement to acquire Fertin Pharma from private equity firm EQT for approximately $812.8m (DKK5.1bn). Denmark-based Fertin Pharma is a specialist contract development